Connect Biopharma Holdings Income Statement (2020-2026) | CNTB

Income Statement Dec2020 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Shares Outstanding (Entity) (Quarter) 2.58M8.16M8.35M7.74M7.86M55.25M55.21M55.35M55.50M55.72M55.66M56.55M
Revenue & cost
Revenue (Quarter) 1.22M0.70M0.05M0.02M0.17M
Operating items
Research & Development (Quarter) 8.66M5.35M9.01M6.24M6.63M8.77M11.11M11.28M15.03M
Selling, General & Administrative (Quarter) 3.97M5.12M6.06M4.08M4.81M4.70M6.58M4.24M4.75M
Operating Expenses (Quarter) 12.63M10.47M15.06M10.32M11.45M13.47M17.69M15.53M19.78M
Operating Income (Quarter) -12.63M13.65M-13.85M-9.62M-11.45M-13.42M-17.68M-15.53M-19.61M
EBIT (Quarter) -12.63M13.65M-13.85M-9.62M-11.45M-13.42M-17.68M-15.53M-19.61M
Non-operating items
Interest & Investment Income (Quarter) 1.25M1.22M1.14M0.85M0.72M0.62M0.55M0.38M0.26M
Other Non Operating Income (Quarter) 2.72M0.01M-0.11M-0.03M0.51M-0.04M-0.01M0.06M-0.00M
Non Operating Income (Quarter) 3.97M1.23M1.03M0.82M1.23M0.58M0.54M0.44M0.26M
Net income details
EBT (Quarter) -8.66M14.88M-12.82M-8.80M-10.22M-12.84M-17.14M-15.08M-19.35M
Tax Provisions (Quarter) 0.03M0.03M0.06M0.11M0.05M0.06M0.06M0.03M0.05M
Profit After Tax (Quarter) -8.69M14.85M-12.88M-9.56M-10.27M-12.90M-17.20M-15.11M-19.40M
Income from Non-Controlling Interests (Quarter) 0.01M0.00M0.00M-0.00M-0.01M0.01M-0.01M-0.00M
Income from Continuing Operations (Quarter) -8.69M14.85M-12.88M-8.91M-10.27M-12.90M-17.20M-15.11M-19.40M
Consolidated Net Income (Quarter) -8.69M14.85M-12.88M-8.91M-10.27M-12.90M-17.20M-15.11M-19.40M
Income towards Parent Company (Quarter) -8.69M14.85M-12.88M-8.91M-10.27M-12.90M-17.20M-15.11M-19.40M
Net Income towards Common Stockholders (Quarter) -8.69M14.85M-12.88M-8.91M-10.27M-12.90M-17.20M-15.11M-19.40M
Additional items
EPS (Basic) (Quarter) -0.160.27-0.23-0.16-0.19-0.23-0.31-0.27-0.34
EPS (Diluted) (Quarter) -0.160.27-0.23-0.16-0.19-0.23-0.31-0.27-0.34
Shares Outstanding (Quarter) 17.09M52.18M55.06M55.04M55.05M55.07M55.10M55.19M55.25M55.21M55.35M55.50M55.72M55.66M56.55M
Shares Outstanding (Diluted) (Quarter) 55.05M55.07M55.10M55.71M55.25M55.21M55.35M55.50M55.72M55.66M56.55M
EBITDA (Quarter) -12.63M13.65M-13.85M-9.62M-11.45M-13.42M-17.68M-15.53M-19.61M
Interest Expenses (Quarter) 0.44M0.02M0.02M64.36M0.10M0.07M0.08M0.07M0.08M0.97M0.11M0.13M0.74M
Tax Rate (Quarter) -0.350.20-0.44-1.20-0.53-0.43-0.36-0.18-0.25